1: A Randomized Phase III Trial Comparing Health-Related Quality of Life After Low Dose Rate (LDR) or High Dose Rate (HDR) Prostate Brachytherapy Boost Combined with External Beam Pelvic Radiotherapy (EBRT). (September 2022)